These findings were also shown by Cil et al., who demonstrated the association between higher NT-proBNP levels and reduced LVEF in asymptomatic breast cancer patients after doxorubicin administration and they stated that this could be an early indication of subclinical acute anthracycline cardiotoxicity. This evidence concerns the gene NPPB and breast cancer.